Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.
Chariot
P
P
Hôpital Henri Mondor, Créteil, France.
Abadia
R
R
Agnus
D
D
Danan
C
C
Charpentier
C
C
Gherardi
R K
RK
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin / Q000009:adverse effects / Q000031:analogs & derivatives*; D017241:MELAS Syndrome / Q000209:etiology*; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000150:complications; D019821:Simvastatin
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; D019821:Simvastatin